Skip to main content

Lungo Peccorini, Ana Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Lungo Peccorini, Ana Gabriela

Institutions of which they are part

Research technician
Pediatric Neurology
Vall Hebron Institut de Recerca

Related news

The clinical trial, which also involved Vall d’Hebron, shows that the new therapy improves survival by 86% in patients with thymidine kinase 2 deficiency (TK2d).

The ClinPrior algorithm achieved a positive diagnosis rate of 70% in two minority diseases of neurodegenerative origin, which represents double the number of cases that are diagnosed with current tools.

Over the course of two days, experts presented the latest advances in vectors, different gene modification techniques and their transfer to clinical practice.

Related professionals

Samuel Sánchez Pous

Samuel Sánchez Pous

Predoctoral researcher
Clinical Neuroimmunology
Read more
Irene Corrales  Insa

Irene Corrales Insa

Main researcher
Transfusional Medicine
Read more
Cèlia Milà Augé

Cèlia Milà Augé

Pneumology
Read more
Mª Jesus Melia Grimal

Mª Jesus Melia Grimal

Research technician
Neuromuscular and Mitochondrial Pathology
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.